“After progress in a second round of tests using stem cells to regrow nerve fibres, the China Spinal Cord Injury Network (ChinaSCINet) has applied for regulatory approval in China for a third and final phase, which it hopes to start in the autumn. 15 out of 20 patients in the Chinese city of Kunming, who received umbilical cord blood cell transplants and intensive walking therapy, were on average able to walk with minimal assistance seven years after complete spinal cord injury. The treatment involves injecting umbilical cord blood mononuclear cells into patients’ damaged spines to help regenerate nerves, while lithium is used to promote the growth of the nerve fibres.”
(Visited 75 times, 1 visits today)
Related posts:
Half of Affordable Care Act call center jobs will be part-time
FBI is investigating former Utah trooper Lisa Steed
What Really Drove the Children North
Work in U.S. and Spain losing its appeal for Latin Americans
Tech-savvy Vietnamese coffee farmers brew global takeover
Smog crisis creates ‘apocalyptic’ conditions in Singapore
Walmart may cancel three planned D.C. stores over 'livable wage' act
Debate intensifies over ‘draconian’ cyber crime laws after Aaron Swartz’s death
Unicorns Hunt for Talent Among Silicon Valley’s Giants
Dutch police launch criminal investigation into Uber
18 different minimum wages in American Samoa, 30% jobless rate
U.S. household stock wealth at highest level since dotcom bubble
How the U.S. DEA program differs from recent NSA revelations
Federal Lawsuit Questions if Washington State Can Tax Marijuana
Merkel, the Red footsoldier: Photos of German chancellor's Communist uniform released